The content on this site is intended for healthcare professionals only
Prof McVie talks to ecancertv at the 1st international symposium on radiotherapy and oncology in Chile, about the latest in proton beam therapy.
He discusses how costs have previously been prohibitive to a country's ability to offer this treatment and weighs up the benefits of proton beam therapy against conventional radiotherapy.
Applications and access to proton beam therapy were discussed at the American Society of Clinical Oncology's annual congress by Dr Zhongxing Liao, here, and Dr Madhusmita Behera, here.
The evolving paradigm in management of Multiple Myeloma
Hope vs Hype of evidence interpretation
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
Latest in immunological technologies that can treat, control, and prevent cancer
Rationale for routine use of IORT for early breast cancer and data for specific indications
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
